Authors:
MEURICE F
DEBOUVER JL
VANDEVOORDE D
WOODS S
BOGAERTS H
Citation: F. Meurice et al., IMMUNOGENICITY AND SAFETY OF A LIVE ATTENUATED VARICELLA VACCINE (OKASB BIO) IN HEALTHY-CHILDREN/, The Journal of infectious diseases, 174, 1996, pp. 324-329
Authors:
RAMKISSOON A
COOVADIA HM
JUGNUNDAN P
HAFFEJEE IE
MEURICE F
VANDEVOORDE D
Citation: A. Ramkissoon et al., IMMUNOGENICITY AND SAFETY OF A LIVE ATTENUATED VARICELLA VACCINE IN HEALTHY INDIAN CHILDREN AGED 9-24 MONTHS, South African medical journal, 85(12), 1995, pp. 1295-1298
Authors:
VANURA H
JUST M
AMBROSCH F
BERGER RM
BOGAERTS H
WYNEN J
VANDEVOORDE D
WIEDERMANN G
Citation: H. Vanura et al., STUDY OF PERTUSSIS VACCINES IN INFANTS - COMPARISON OF RESPONSE TO ACELLULAR PERTUSSIS DTP VACCINES CONTAINING 25 MU-G OF FHA AND EITHER 25OR 8 MU-G OF PT WITH RESPONSE TO WHOLE-CELL PERTUSSIS DTP VACCINE, Vaccine, 12(3), 1994, pp. 210-214
Authors:
KANRA G
CEYHAN M
VANDEVOORDE D
BOGAERTS H
Citation: G. Kanra et al., ACELLULAR PERTUSSIS DIPHTHERIA-TETANUS-PERTUSSIS VACCINE CONTAINING SEPARATELY PURIFIED PERTUSSIS TOXOID, FILAMENTOUS HEMAGGLUTININ AND 69 KDA OUTER-MEMBRANE PROTEIN AS A BOOSTER IN CHILDREN, European journal of pediatrics, 152(6), 1993, pp. 478-483